Azasugar inhibitors as pharmacological chaperones for Krabbe disease
作者:Chris H. Hill、Agnete H. Viuff、Samantha J. Spratley、Stéphane Salamone、Stig H. Christensen、Randy J. Read、Nigel W. Moriarty、Henrik H. Jensen、Janet E. Deane
DOI:10.1039/c5sc00754b
日期:——
Modified azasugar molecules have been synthesized and characterized as excellent pharmacological chaperone candidates to treat the neurodegenerative disorder Krabbe disease.
改良的azasugar分子已被合成并表征为治疗神经退行性疾病Krabbe病的优秀药理伴侣候选者。
Isogalactofagomine lactam. A neutral nanomolar galactosidase inhibitor
作者:Helmer Søhoel、Xifu Liang、Mikael Bols
DOI:10.1039/b103831c
日期:——
4-Deoxy-4-hydroxymethyl-L-ribono-1,5-lactam (9) was synthesised and found to be a potent inhibitor of β-galactosidase from Aspergillus oryzae with a Ki of 18 nM.